World-class
market experts
guide you to
invest smarter
& trade wiser.

1,337 Experts | 29 Virtual Expos
5 Conferences | 55 Courses
33,204 Articles | 4,043 Videos

Conferences


Virtual Learning

Tom Smith will provide an overview of WRAP Technologies and how it is helping improve policing and law enforcement globally by providing tools that reduce the use of force to apprehend subjects. He will discuss WRAP's current technologies, the BolaWrap remote restraint device and WRAP Reality simulation-based training platform, as well as the growing market interest both in the US and internationally, new and extended BolaWrap pilot programs, and successful police field uses preventing escalation of force. He will also talk about WRAP's strong first-quarter 2021 financial results and operating metrics.
From the retail investor appetite for micro-options contracts to the benefits of utilizing index options, explore strategies to incorporate new investment vehicles into your portfolio.

The best options trading strategy identifies stock moves before they happen so you can get in ahead of the herd, applies the right options combination to maximize probability with the potential for 100%+ ROI every time, and works consistently in both normal and volatile market conditions.

In his presentation Matt Choi, CMT, will show you how to find and place options trades to double your investment every time with this one strategy. After this 45-minute class, you'll have all the step-by-step instructions to start trading his strategy right away. This is a must-have for serious options traders.



With the recent acquisition of GWPH by Jazz Pharmaceuticals, many investors are wondering who might follow in their footsteps. Skye Bioscience (SKYE) has the right set-up—and advantages—to not just follow GW's leadership but carve a new path. SKYE is working to solve the world's leading cause of irreversible blindness by applying advanced science to uniquely unlock the therapeutic potential of cannabinoids and create important new pharmaceutical medicines. The lead program targets glaucoma, a disease with no cure and the world's leading cause of irreversible blindness. Preclinical data has demonstrated that SKYE's lead molecule, THCVHS, provides superior lowering of intraocular pressure, a key cause of vision loss, compared to the top commercially marketed classes of drugs that represent 80% of a nearly $7 billion market opportunity. With key value driving milestone and catalyst on the horizon SKYE is poised for significant growth.
Against the backdrop of heightened tensions in US-China relations, strong economic data, and raw-material shortages and supply-chain issues, what can investors expect for the rest of the year? Our distinguished panel will dissect the economic, global trade, and political landscape and offer a unique perspective on the long- and short-term implications of these factors and more on your portfolio.
A major driver of cancer is defects in the switches that turn the biochemical pathways in cells on and off. Most cancer research over the past 30 years has focused on the on switches because the off switches, especially the master off switch protein phosphatase (PP2A), were believed to cause intolerable toxicity in patients. Lixte has achieved a breakthrough with its novel, first-in-class lead compound, PP2A inhibitor LB-100, by demonstrating that it is readily tolerated in cancer patients at doses associated with anti-cancer activity. This innovative approach encourages cancer cells, weakened by chemo or other cancer therapies, to continue to replicate, leading to the more efficient death and elimination of those cells from the body.
Emerald Health Therapeutics is committed to creating new consumer and patient experiences with specialty recreational, medical, and wellness-oriented cannabinoid products. The company is focused on science-based innovation and product excellence, leveraging competencies in scientific know-how and research and development. Emerald is serving consumers and patients in Canada and establishing partnerships that extend its product lines and international reach.
Learn how to earn consistent passive income and diversify your portfolio with one simple investment vehicle. In this session, the managing partners of Bequest Funds, Martin Saenz and Shawn Muneio, explain how their fund leverages the secondary mortgage market to generate 8% or 9% annual preferred returns for investors. Monthly payments from borrowers become monthly passive income for investors. Join us to learn more about Bequest Funds' conservative underwriting model and investor benefits including monthly passive income distributions, zero fees, and investment liquidity following a mere 12-month lock-in period. Earn consistent income and diversify your portfolio to include real estate assets with Bequest Funds.
As performance perseveres, trends accelerate, and technology continues to lead the way, discover why the right volatility signals matter for your portfolio.
Lee Ohanian will discuss the outlook for the US economy under record fiscal deficits and monetary expansion. He will focus on future economic growth, inflation, and fiscal challenges that we will be facing.

Kristina Hooper will share the base case for the economy in the back half of 2021 and asset implications. She will also explore two tail-risk scenarios, high inflation and a pandemic resurgence, and their respective asset class implications.

Virtual Expos




A 40-Year Passion and History

MoneyShow has a long history of creating successful investors and traders through timely investing and trading education, delivered by powerful experts who are best-selling authors, market analysts, portfolio managers, award-winning financial journalists, and newsletter editors. With MoneyShow’s interactive environment, our audience of over one million passionate investors and traders are offered a unique format of live, interactive exchange, which generates unparalleled experience for both the expert and the investor and trader.

With constant network expansion, we continue to create broader distribution of our expert commentary through virtual events, face-to-face forums, social media, and in-depth courses that educate and guide qualified investors and traders to outperform the market. Each session energizes, empowers, and educates everyone who participates. The opportunity for learning and profit within this highly charged atmosphere draws hundreds of thousands of enthusiasts, year after year.

View Courses